Neural Plasticity and Motor Recovery After Early and Intensive Upper Extremity Motor Training in People With c-SCI (REPAIR-SCI)

October 2, 2023 updated by: Annemie Spooren

Neural Plasticity and Motor Recovery After Early and Intensive Upper Extremity Motor Training in People With Cervical Spinal Cord Injury

After spinal cord injury (SCI), there is a disruption in neural circuits resulting in paralysis. There is not yet a cure for paralysis. In persons with Cervical SCI (pwC-SCI) recovery of arm-hand function is very important as it has a significant impact on the patients' level of independence and quality of life. Recovery is assumed to involve alterations in both central and peripheral motor systems. Motor training at an intensive dosage potentially provides a powerful stimulus for neurological recovery. This project exploits the peripheral and central neuroplastic effect of an early (<10 weeks after injury) and intensive (10 weeks of 12 hours in addition to usual care) upper limb motor training program (EIUMT) directed at recovery below the level of the injury in pwC-SCI within an international multi-center randomized controlled trial including 40 pwC-SCI. It has 4 objectives: to investigate 1)central neural plasticity by identifying alterations in cortical neuroplasticity and corticospinal excitability; 2)peripheral neural plasticity by identifying alteration in axonal excitability and number of motor units; 3)behavioral motor recovery of upper limb and 4)relationships between dose dimensions of motor intervention and behavioral and neurophysiological outcome measures aer EIUMT. Cutting-edge neurophysiological measures are used to provide insight in the mechanism of neuroplasticity after EIUMT and will be taken before and after EIUMT and at 6 months follow-up.

Study Overview

Status

Not yet recruiting

Detailed Description

Background of the study:

Paralysis or paralysis is the most common effect of spinal cord injury (SCI) on individuals. Paralysis affects the ability to walk, perform self-care, live independently and participate in work and leisure activities. In individuals with cervical spinal cord injury, arm and hand function is very important. The most promising and easily implemented intervention that could promote neurological recovery and make a lasting difference in the lives of people with spinal cord injury is early and intensive motor training aimed at recovery below the injury level. This intervention takes advantage of the early plasticity of the nervous system. By maximizing muscle activation in the first few days after injury, we can target the nervous system's unique capacity for neural plasticity where changes can occur in central and peripheral motor systems.

Objective of the study:

This project aims to investigate peripheral and central neuroplasticity following an early (<10 weeks after injury) and intensive (10weeks of 12 hours of additional therapy) upper extremity motor training program (EIUMT) aimed at recovery below the lesion level.This project has 4 objectives: to investigate 1) central neural plasticity (identify changes in cortical neuroplasticity and corticospinal excitability; 2) peripheral neural plasticity (identify change in axonal excitability and number of motor units); 3) clinical motor recovery of the upper limbs and 4) relationships between dose dimensions of motor intervention and clinical and neurophysiological outcome measures after EIUMT. Advanced neurophysiological measurements and clinical measurements will be taken before and after EIUMT and at 6-month follow-up.

Study design:

a multicenter pragmatic randomised controlled study in 2 countries

Study population:

40 persons with cervical spinal cord injury (20 participants in the control and intervention groups) Inclusion criteria: Individuals are eligible to participate if they have suffered a traumatic or non-traumatic cervical spinal cord injury(with neurological level C4 or below) within the previous 10 weeks, have AIS (ASIA Impairment Scale) A lesion with motor function more than three levels below motor level (on one or both sides) or have AIS C or AIS D lesion (as defined by the International Standards for the Neurological Classification of spinal cord injury), are older than 16 years of age, have received permission to begin rehabilitation and are likely to remain an inpatient for the next 10 weeks.

Exclusion criteria: Participants will be excluded if they have a significant medical or physical condition or psychiatric illness that could prevent the person from participating in the study, or would place the person at unacceptable risk if they were to participate.

Intervention:

The intervention group receives 12 hours of motor training each week. This involves active and targeted motor training of all affected muscles below the injury level in the context of functional activities.

The control group receives only standard rehabilitation and care.

Primary study parameters/outcome of the study:

Central plasticity via: Single pulse TMS (transcranial magnetic stimulation) (cortical mapping and rest motor threshold) 10 weeks after randomisation

Secundary study parameters/outcome of the study:

Clinical Measures: Upper Extremity Motor Score, Spinal Cord Independence Measure (SClM-zelfzorg); Van Lieshout Test (VLT);Grades redefined assessment of strength sensibility and Prehension (GRASSP); Hand-Held Dynamometry; accelerometry (session density: active therapy time/session length); perceived difficulty and exertion) Central plasticity: Paired pulse TMS: (SICI (short interval intracortical inhibition); LICI (long interval intracortical inhibition); SICF (short interval intracortical inhibition); peripheral plasticity: NET (Nerve excitability testing) en MScanFit MUNE(Compound muscle action potential (CMAP).

Study Type

Interventional

Enrollment (Estimated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Gent, Belgium
        • UZGent
        • Contact:
          • Kristine Oostra, Prof. Dr.
      • Leuven, Belgium
        • UZLeuven Campus Pellenberg
        • Contact:
          • Koen Peers, Prof. Dr.
      • Hoensbroek, Netherlands
        • Zorggroep Adelante
        • Contact:
          • Charlotte Van Laake, dr.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Traumatic or non-traumatic C-SCI below C4 in the preceding 10 weeks; age over 16 years; have an incomplete SCI or an AIS A SCI with zones of partial motor paralysis (as defined by the International Standards for the Neurological Classification of SCI (ISNCI) and medically stable.

Exclusion Criteria:

  • SCI with ASIA Impairment Scale (AIS) A without zones of partial preservation (decided based on former studies [58]) and expertise of the team; SCI with any significant medical condition that could prevent the person from participating. In order to ensure TMS measurement can be performed, patients will only be included for this measure if they have a positive response to motor evoked potential measurement (MEP+) [59] and will be excluded in the presence of contraindications for TMS application such as epilepsy, metal implants in the brain,defibrillator, pacemaker and pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: intensive upper limb training
The intervention group receives 12 hours of motor training each week upon usual care during 10 weeks. This involves active and targeted motor training of all affected muscles below the injury level in the context of functional activities.
Intervention group: receive an extra 12 hours of motor training each week (distributed over the week) for 10 weeks. It will involve active and targeted motor training of all affected muscles of the upper limb below the level of the injury within the context of practice of functional activities. Interventions will be goal directed and individualized to the needs of each participant with a focus on training that addresses each person's specific motor problem, promoting motor learning as well as stimulating neural plasticity. All patients will continue to receive usual physiotherapy and usual rehabilitation.
Other: usual care
The control group receives only standard rehabilitation and care
usual rehabilitation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
changes in single pulse TMS: mapping
Time Frame: before intervention; at 10 weeks (after intervention) and at 6 months follow-up
to evaluate changes in cortical reorganisation
before intervention; at 10 weeks (after intervention) and at 6 months follow-up
changes in single pulse TMS: resting motor threshold
Time Frame: before intervention; at 10 weeks (after intervention) and at 6 months follow-up
to asses changes in cortical reactivity
before intervention; at 10 weeks (after intervention) and at 6 months follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
changes SICI
Time Frame: before intervention; at 10 weeks (after intervention) and at 6 months follow-up
to evaluatie changes in Short interval intracortical inhibition
before intervention; at 10 weeks (after intervention) and at 6 months follow-up
changes SICF
Time Frame: before intervention; at 10 weeks (after intervention) and at 6 months follow-up
short-interval intracortical facilitation
before intervention; at 10 weeks (after intervention) and at 6 months follow-up
changes in LICI
Time Frame: before intervention; at 10 weeks (after intervention) and at 6 months follow-up
long-interval intracortical inhibition
before intervention; at 10 weeks (after intervention) and at 6 months follow-up
changes in MscanFit MUNE
Time Frame: before intervention; at 10 weeks (after intervention) and at 6 months follow-up
Compound muscle action potential (CMAP) scans will be recorded
before intervention; at 10 weeks (after intervention) and at 6 months follow-up
changes in NET (Nerve excitability testing)
Time Frame: before intervention; at 10 weeks (after intervention) and at 6 months follow-up
Strength duration time constant (SDTC), threshold electrotonus (TE), I/V relationship (I/V) and recovery cycles (RC) will be measured.
before intervention; at 10 weeks (after intervention) and at 6 months follow-up
changes in behavioral measures: Upper extremity motor score
Time Frame: before intervention; at 10 weeks (after intervention) and at 6 months follow-up
score on 50
before intervention; at 10 weeks (after intervention) and at 6 months follow-up
changes in Spinal Cord independence Measures
Time Frame: before intervention; at 10 weeks (after intervention) and at 6 months follow-up
questionaire: self-care score
before intervention; at 10 weeks (after intervention) and at 6 months follow-up
changes in Van Lieshout Test
Time Frame: before intervention; at 10 weeks (after intervention) and at 6 months follow-up
basis upper extremity skills
before intervention; at 10 weeks (after intervention) and at 6 months follow-up
changes in GRASSP
Time Frame: before intervention; at 10 weeks (after intervention) and at 6 months follow-up
Grades redefined assessment of strength sensibility and Prehension
before intervention; at 10 weeks (after intervention) and at 6 months follow-up
changes in hand held dynamometry
Time Frame: before intervention; at 10 weeks (after intervention) and at 6 months follow-up
strength in hand
before intervention; at 10 weeks (after intervention) and at 6 months follow-up

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
therapy difficulty
Time Frame: before session; after completion of session an average of 60 minutes
VAS
before session; after completion of session an average of 60 minutes
session density
Time Frame: start intervention up to 10 weeks
accelerometry
start intervention up to 10 weeks
therapy perceived exertion
Time Frame: before session; after completion of session an average of 60 minutes
VAS
before session; after completion of session an average of 60 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

October 5, 2023

Primary Completion (Estimated)

August 28, 2026

Study Completion (Estimated)

February 28, 2027

Study Registration Dates

First Submitted

June 14, 2023

First Submitted That Met QC Criteria

October 2, 2023

First Posted (Actual)

October 3, 2023

Study Record Updates

Last Update Posted (Actual)

October 3, 2023

Last Update Submitted That Met QC Criteria

October 2, 2023

Last Verified

October 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

pseudomised data will be shared with the Aarhys university because they will assist in data-analyses.

the protocol will be shared with the partners (Aarhus University, Sydney University, UZGent, UZLeuven and Adelante Zorggroep)

IPD Sharing Time Frame

during and after datagathering

IPD Sharing Access Criteria

only for collaborating partners

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ANALYTIC_CODE

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Spinal Cord Injuries

Clinical Trials on experimental group: intensive motor training

3
Subscribe